Get Details

Leadership

With deep experience in oncology drug development and protein engineering, our team embodies the “leading edge” of immunotherapy progress.

David Campbell, Ph.D.

Founder, President & Chief Executive Officer

Byron Robinson, Ph.D., J.D.

Chief Strategy Officer

Tommy DiRaimondo, Ph.D.

Chief Scientific Officer

Janeen Doyle

Chief Corporate and Business Development Officer

Zachariah McIver, D.O., Ph.D.

Chief Medical Officer

Andy Meyer

Chief Business Officer

Charles Winter

Chief Technical Officer

Carolina Caffaro, Ph.D.

Vice President, CMC Process Development

Jenna Daly

Vice President, Clinical Operations

Maria Dobek

Vice President, Accounting

Matt Whitmire

Vice President, Finance

James Pennington

General Counsel

David Campbell, Ph.D.

Founder, President & Chief Executive Officer

Byron Robinson, Ph.D., J.D.

Chief Strategy Officer

Tommy DiRaimondo, Ph.D.

Chief Scientific Officer

Janeen Doyle

Chief Corporate and Business Development Officer

Zachariah McIver, D.O., Ph.D.

Chief Medical Officer

Andy Meyer

Chief Business Officer

Charles Winter

Chief Technical Officer

Carolina Caffaro, Ph.D.

Vice President, CMC Process Development

Jenna Daly

Vice President, Clinical Operations

Maria Dobek

Vice President, Accounting

Matt Whitmire

Vice President, Finance

James Pennington

General Counsel

Ron Barrett, Ph.D.

Chairperson

David Campbell, Ph.D.

President & CEO

Vickie Capps

Eric Dobmeier, J.D.

Sheila Gujrathi, M.D.

Natasha Hernday

Winston Kung

Alana McNulty

Jake Simson, Ph.D.

Ron Barrett, Ph.D.

Chairperson

David Campbell, Ph.D.

President & CEO

Vickie Capps

Eric Dobmeier, J.D.

Sheila Gujrathi, M.D.

Natasha Hernday

Winston Kung

Alana McNulty

Jake Simson, Ph.D.

Julie Cherrington, Ph.D.

Mark M. Davis, Ph.D.

Greg Weiss, Ph.D.

Julie Cherrington, Ph.D.

Mark M. Davis, Ph.D.

Greg Weiss, Ph.D.

For more information about Janux or to engage with us, reach out and let’s connect.

View contact page